Jupiter Neurosciences director exercises 82,875 RSUs
JUPITER NEUROSCIENCES, INC. director Julie B. Kampf reported the vesting and exercise of 82,875 restricted stock units on June 2, 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
JUPITER NEUROSCIENCES, INC. director Julie B. Kampf reported the vesting and exercise of 82,875 restricted stock units on June 2, 2025. These RSUs converted into common stock on a one-for-one basis at $0.00 per unit upon expiration of the IPO lock-up period, leaving her with 82,875 common shares held directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units F1, F2 | 82,875 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 82,875 | -- | -- |
Footnotes (2)
- F1. These restricted stock units convert into common stock on a one-for-one basis.
- F2. Represents restricted stock units which vested on the expiration of the lock-up period for the Issuer's initial public offering.
Key Figures
Key Terms
Restricted Stock Units financial
lock-up period financial
initial public offering financial
derivative security financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did JUNS director Julie B. Kampf report on this Form 4?
What type of securities did the JUNS RSUs convert into for Julie B. Kampf?
Why did the JUNS restricted stock units vest on June 2, 2025?
AI-generated analysis. How Rhea-AI works. Not financial advice.